Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 125

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 125
---
rupt Practices Act, and any other applicable Laws of any jurisdiction that prohibits payments to 
 improperly influence Government Officials or private                                                                                                                                                                             |

E-13

| individuals (collectively, “Anti-Corruption Laws”). Neither the Company, nor, to the knowledge of the Company, any director, officer, employee, agent, distributor, consultant,                                                                      
 affiliate or other person acting on behalf of the Company has, taken any action, either directly or indirectly, that would result in a violation of the Anti-Corruption Laws, including making, offering, authorizing or promising any payment,      
 contribution, gift, entertainment, bribe, rebate, kickback or any other thing of value, regardless of form or amount, to any (i) foreign or domestic Government Official or Person of Concern; (ii) employee of a foreign or domestic                
 government owned or controlled entity; (iii) foreign or domestic political party, political official or candidate for political office; (iv) any officer or employee of a public international organization; (v) any employee or official            
 of an indigenous group; or (vi) any other person, in each case, to obtain a business or competitive advantage, as consideration for an act, omission, or influence to receive favourable treatment in obtaining or retaining business, or to pay for 
 favourable treatment already secured.                                                                                                                                                                                                                |

| (b) | Neither the Company nor, to the knowledge of the Company, any director, officer, employee, agent, distributor,                                                                                                                                  
 consultant, affiliate or other person acting on behalf of the Company is (i) or in the past five years has been, under administrative, civil or criminal investigation, indictment, information, suspension, debarment or audit (other than a   
 routine contract audit) by any Party, in connection with alleged or possible violations of the Anti-Corruption Laws; or (ii) has within the past five years received notice from, or made a voluntary disclosure to, the Royal Canadian Mounted 
 Police or other Governmental Entity regarding alleged or possible violations of the Anti-Corruption Laws.                                                                                                                                       |

| (c) | To the knowledge of the Company, neither the Company, nor any director, employee, affiliate or agent of the                                                                                                                            
 Company, or any person acting on the Company’s or its Subsidiary’s behalf, has, in connection with, or otherwise relating to, the operation of the Company’s business, engaged in any activity or conduct that has resulted in or will 
 result in a violation of any applicable antitrust